𝔖 Bobbio Scriptorium

✦ LIBER ✦

Safety and efficacy of more than 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

Book ID: 116583881
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 53 KB
Volume: 58
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2007.10.476

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of up to eight years

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

✍ Daniel J. Lovell; Andreas Reiff; Norman T. Ilowite; Carol A. Wallace; Yun Chon; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Global safety and efficacy of more than

Global safety and efficacy of more than 5 years of etanercept therapy in rheumatoid arthritis

✍ Mark Lebwohl; Alice Gottlieb; Wayne Wallis; Ralph Zitnik 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Safety and efficacy of more than 4 years

Safety and efficacy of more than 4 years of adalimumab therapy in rheumatoid arthritis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Safety and efficacy of up to 9 years of

Safety and efficacy of up to 9 years of etanercept therapy in North American patients with rheumatoid arthritis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety and efficacy of over 7 years of e

Safety and efficacy of over 7 years of etanercept therapy in a global population of patients with rheumatoid arthritis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety and efficacy of etanercept beyond

Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis

✍ Michael E. Weinblatt; Joan M. Bathon; Joel M. Kremer; Roy M. Fleischmann; Michae 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 202 KB 👁 2 views